Hotchkis & Wiley Capital Management LLC Biogen Inc. Transaction History

Hotchkis & Wiley Capital Management LLC

$27.9 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $38,938 - $53,691	200 Added 12.5%	1,800 $481,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $51.1 Million - $81.8 Million	-197,311 Reduced 99.2%	1,600 $554,000
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $121,475 - $142,315	-500 Reduced 0.25%	198,911 $55.6 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $1.16 Million - $1.74 Million	-4,900 Reduced 2.4%	199,411 $48.8 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $19.9 Million - $22.9 Million	-75,060 Reduced 26.87%	204,311 $58 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $25,866 - $34,255	-100 Reduced 0.04%	279,371 $74.7 Million
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $2.15 Million - $2.73 Million	8,000 Added 2.95%	279,471 $88.4 Million
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $7.35 Million - $10.2 Million	33,399 Added 14.03%	271,471 $80.6 Million
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $43,488 - $48,776	200 Added 0.08%	238,072 $55.4 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $548,225 - $604,300	-2,500 Reduced 1.04%	237,872 $55.6 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $910,182 - $1.42 Million	-4,200 Reduced 1.72%	240,372 $56.8 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $2.4 Million - $3.03 Million	-8,600 Reduced 3.4%	244,572 $73.6 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $2.91 Million - $3.8 Million	-9,900 Reduced 3.76%	253,172 $89.4 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $1.18 Million - $1.41 Million	-4,600 Reduced 1.72%	263,072 $76.4 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $1.04 Million - $1.47 Million	-4,000 Reduced 1.47%	267,672 $73.3 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $953,684 - $1.07 Million	-3,100 Reduced 1.13%	271,672 $86.5 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $77.3 Million - $90.6 Million	274,772	274,772 $86 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hotchkis & Wiley Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hotchkis & Wiley Capital Management LLC with notifications on news.

Account